TSM

394.35

-1.85%↓

640.26

+11%↑

ASML.US

1,443.91

+4.15%↑

ORCL

185.38

+2.78%↑

INTC

108.17

+13.01%↑

TSM

394.35

-1.85%↓

640.26

+11%↑

ASML.US

1,443.91

+4.15%↑

ORCL

185.38

+2.78%↑

INTC

108.17

+13.01%↑

TSM

394.35

-1.85%↓

640.26

+11%↑

ASML.US

1,443.91

+4.15%↑

ORCL

185.38

+2.78%↑

INTC

108.17

+13.01%↑

TSM

394.35

-1.85%↓

640.26

+11%↑

ASML.US

1,443.91

+4.15%↑

ORCL

185.38

+2.78%↑

INTC

108.17

+13.01%↑

TSM

394.35

-1.85%↓

640.26

+11%↑

ASML.US

1,443.91

+4.15%↑

ORCL

185.38

+2.78%↑

INTC

108.17

+13.01%↑

Home・Akcijų sąrašas・Genpact Ltd

Genpact Ltd

Uždarymo kaina

SektoriusTechnologijų sektorius

34.08 -0.18

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

33.12

Max

34.14

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-2.7M 143M
Pardavimai	28M 1.3B
P/E Sektoriaus vid.	10.808 86.001
Dividendų pajamingumas	1.98
Pelno marža	10.846
Darbuotojai	146,500
EBITDA	-29M 201M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+33.57% upside

Dividendai
By Dow Jones
Dividendų pajamingumas Sektoriaus vid.	1.98% 2.73%

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-1.9B 5.7B
Ankstesnė atidarymo kaina	34.26
Ankstesnė uždarymo kaina	34.08

Naujienos nuotaikos

By Acuity

50%

169 / 374 reitingas Technology

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

4.95 / N/A Palaikymas ir pasipriešinimas

Genpact Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-12 11:32; UTC

Uždarbis

Italian Insurer Generali Posts Rise in Profit -- Update

2026-03-12 11:20; UTC

Uždarbis

Correction to Generali Flash Headlines

2026-03-12 06:29; UTC

Uždarbis

Italian Insurer Generali Posts Rise in Profit on Growth Across Segments

2026-04-15 06:09; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Generali Could Consider Capital-Light M&A to Grow Franchise, Deputy CEO Says -- Market Talk

2026-03-12 08:27; UTC

Rinkos pokalbiai

Generali's AI Disclosure Is Pleasing -- Market Talk

2026-03-12 07:01; UTC

Rinkos pokalbiai

Uždarbis

Generali's Beat Should Get Positive Share Reaction -- Market Talk

2026-03-12 06:04; UTC

Uždarbis

Generali Backs 2027 View

2026-03-12 06:04; UTC

Uždarbis

Generali 2025 Life PVNBP EUR55.55B

2026-03-12 06:04; UTC

Uždarbis

Analysts Saw Generali 2025 Life PVNBP EUR56.03B

2026-03-12 06:04; UTC

Uždarbis

Analysts Saw Generali 2025 Life New Business Value EUR3.05B

2026-03-12 06:04; UTC

Uždarbis

Generali 2025 Life New Business Value EUR3.15B

2026-03-12 06:04; UTC

Uždarbis

Generali End-2025 Solvency Ratio 219%

2026-03-12 06:04; UTC

Uždarbis

Analysts Saw Generali End-2025 Solvency Ratio 212%

2026-03-12 06:04; UTC

Uždarbis

Analysts Saw Generali 2025 Undiscounted Combined Ratio 94.2%

2026-03-12 06:04; UTC

Uždarbis

Analysts Saw Generali 2025 Combined Ratio 92.5%

2026-03-12 06:04; UTC

Uždarbis

Generali 2025 Combined Ratio 92.6%

2026-03-12 06:04; UTC

Uždarbis

Generali 2025 Undiscounted Combined Ratio 94.3%

2026-03-12 06:04; UTC

Uždarbis

Analysts Saw Generali 2025 Dividend EUR1.59

2026-03-12 06:04; UTC

Uždarbis

Analysts Saw Generali 2025 Adj. Net Pft EUR4.31B

2026-03-12 06:04; UTC

Uždarbis

Generali Declares Dividend of EUR1.64

2026-03-12 06:04; UTC

Uždarbis

Generali 2025 Adj. Net Pft EUR4.315B

2026-03-12 06:04; UTC

Uždarbis

Generali Announces EUR500M Buyback for 2026

2026-03-12 06:04; UTC

Uždarbis

Generali 2025 Net Inflows EUR16B

2026-03-12 06:04; UTC

Uždarbis

Generali End-2025 Assets Under Management EUR899.93B

2026-03-12 06:04; UTC

Uždarbis

Generali 2025 Net Pft EUR4.17B

2026-03-12 06:04; UTC

Uždarbis

Analysts Saw Generali 2025 Oper Result EUR7.965B

2026-03-12 06:04; UTC

Uždarbis

Analysts Saw Generali 2025 Net Pft EUR4.225B

2026-03-12 06:04; UTC

Uždarbis

Generali 2025 Life Written Premiums EUR61.94B

2026-03-12 06:04; UTC

Uždarbis

Analysts Saw Generali 2025 Life Written Premiums EUR62.795B

2026-03-12 06:04; UTC

Uždarbis

Generali 2025 Gross Written Premiums EUR98.12B

Akcijų palyginimas

Kainos pokytis

Genpact Ltd Prognozė

Kainos tikslas

By TipRanks

33.57% į viršų

12 mėnesių prognozė

Vidutinis 45.6 USD 33.57%

Aukščiausias 55 USD

Žemiausias 37 USD

Remiantis 5 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Genpact Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

5 ratings

Pirkti

Laikyti

Parduoti

Remiantis 5 analitikų, pateikusių Genpact Ltd akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

4.95 / N/APalaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Rinkos nuotaikos

By Acuity

169 / 374 reitingas Technologijų sektorius

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Genpact Ltd

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims. The Consumer and Healthcare segment provides demand generation, sensing and planning, supply chain planning and management, pricing and trade promotion management, deduction recovery management, order management, and digital commerce; and end-to-end claim lifecycle management, from claims processing and adjudication to claims recovery and payment integrity, revenue cycle management, health equity analytics, and care services. The High Tech and Manufacturing segment offers industry-specific solutions for trust and safety, advertising sales support, customer and user experience, and customer care support; and direct and indirect procurement, logistics, field, aftermarket support, and engineering services. It also provides digital operation services; data-tech-Al services; finance and accounting services, such as accounts payable, invoice-to-cash, record to report, financial planning and analysis, and enterprise risk and compliance; CFO advisory services; supply chain, and sourcing and procurement services; sales and commercial, and marketing and experience services; and environmental, social and governance services. The company was founded in 1997 and is based in Hamilton, Bermuda.